Jim Cramer - Mad Money NovoCure Limited NVCR-Q DON'T BUY Jan 29, 2025

He used to like this company a lot, but they fail to make money. Revenues are flat.

Jim Cramer - Mad Money

Unlock Rating

$25.520

Stock price when the opinion was issued

Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

BUY

Recommended this in early-2018. Why has it doubled recently? It works. A friend of his used NVCR medical machines, and his life was extended by three years.

BUY

The medical community doesn't recognize this company, but when it does the stock will double.

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Derek Warren

Lincluden Investment Mgmnt

Stockchase Insights

5i Research

Brian Madden

First Avenue Investment Counsel

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money NovoCure Limited NVCR-Q DON'T BUY Jan 29, 2025

You might be interested:

NovoCure Limited(NVCR-Q)

NovoCure Limited(NVCR-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals